Luiz Pereira Da Silva

Title: Luiz Pereira Da Silva: Innovator in Antiparasitic Research

Introduction

Luiz Pereira Da Silva is a prominent inventor based in Paris, France. He has made significant contributions to the field of antiparasitic agents, focusing on innovative solutions to combat malaria and other parasitic diseases. With a total of 2 patents, his work is recognized for its potential impact on public health.

Latest Patents

One of his latest patents is titled "Siderophores as Antiparasitic Agents." This invention involves antiparasitic agents constituted by a siderophore substance that includes at least one hydroxamate group and at least one peptide bond, with a molecular weight of less than 1,000 D, such as aerobactin. The patent also describes a method for isolating these antiparasitic agents through purification from the supernatant of a culture of appropriate bacteria, particularly pathogenic enterobacteria, which can be applied as antimalarial agents.

Another significant patent is "Membrane Protein Having Proteolytic Activity Obtainable from Plasmodium." This immunogenic composition is designed for use as a vaccine against malaria. It comprises an enzymatically active protease with a molecular weight of 76,000 daltons, characterized by its ability to react with protective antibodies originating from monkeys that are resistant to human malaria parasites, particularly Plasmodium falciparum.

Career Highlights

Luiz Pereira Da Silva is affiliated with the Institut Pasteur, a renowned research institution known for its contributions to microbiology and immunology. His work at this prestigious institute has allowed him to focus on developing innovative solutions to combat infectious diseases.

Collaborations

Throughout his career, Luiz has collaborated with notable colleagues, including Catherine Breton and Yves Crenn. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of antiparasitic agents.

Conclusion

Luiz Pereira Da Silva's contributions to the field of antiparasitic research are noteworthy. His innovative patents and collaborations reflect his commitment to advancing public health through scientific discovery. His work continues to inspire future research in combating parasitic diseases.